Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 11
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04294862 | Tissue Distribution, Pharmacokinetics, Safety, and Tolerability After a Single Dose of TNP-2092 in Participants Undergoing Primary Total Hip or Knee Arthroplasty | ||
| NCT06076694 | Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants | ||
| NCT06081712 | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection | ||
| NCT05857163 | Efficacy and Safety of Rifasutenizol (TNP 2198) in Participants With H. Pylori Infection | ||
| NCT06137573 | Human Mass Balance and Biotransformation Study of [14C]TNP-2198 | ||
| NCT06178718 | A Phase 1, Single-center, Double-blind, Placebo-controlled Study of TNP-2092 Capsules, and the Food Effect Study After Single-dose Oral Administration of TNP-2092 Capsules | ||
| NCT06076681 | A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules | ||
| NCT05074134 | Absorption, Metabolism, and Excretion Study of [14C]-TNP-2092 | ||
| NCT06135675 | Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia | ||
| NCT06081699 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants | ||
| NCT03964493 | TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection |
